基于体质与证候辨析的气郁体质主药主方筛选  

Screening of the main medicine and prescription of qi stagnation constitution based on the differentiation and analysis of constitution and syndrome

作　　者：梁嘉玲[1] 倪诚[1] LIANG Jialing;NI Cheng(Beijing University of Chinese Medicine,Beijing 100029,China)

机构地区：[1]北京中医药大学,北京100029

出　　处：《天津中医药》2020年第12期1334-1336,共3页Tianjin Journal of Traditional Chinese Medicine

基　　金：国家自然科学基金面上项目(81673836);国家中医药管理局王琦国医大师传承工作室、王琦老中医药专家传承工作室建设项目;北京中医药薪火传承“3+3”工程王琦名医传承工作站建设项目;北京中医药大学名医工程王琦学术传承工作室建设项目。

摘　　要：针对目前临床上对气郁体质与气郁证候关系的内涵界定不清、二者选药用方不分甚至等同等误区,先从气郁体质与气郁证的辨识内容、调治目的、主药配伍进行解析,继而从辨体用方用药角度,介绍气郁体质调体主药主方。通过探讨,对于提高气郁体质调体选药用方的精准性及防控相关疾病的有效性具有较高的临床指导价值。In clinical practice,the definition of the relationship between qi stagnation constitution and qi stagnation syndrome remains unclear,and the two are not distinguished or even equivalent in the choice of medicine and prescription.For this reason,the paper analyzes the identification content,therapeutic purpose and compatibility of the main drugs.Then it introduces the main medicine and prescription for regulating qi stagnation constitution from the point of treatment based on constitution differentiation.Through the discussion,it has a high clinical value for improving the accuracy of selecting medicine and prescription in regulating qi stagnation constitution,also for enhancing the effectiveness of the prevention and control of related diseases.

关 键 词：气郁体质 气郁证 主药 主方 逍遥散 

分 类 号：R242[医药卫生—中医临床基础]